Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8033582 | 0.75 | MAOA (0.43) | LOXL2 | |
| SCHEMBL25359877 | 0.74 | TP53 (0.38) | — | |
| SCHEMBL10932716 | 0.74 | TP53 (0.38) | — | |
| SCHEMBL2526309 | 0.74 | IDO1 (0.38) | — | |
| SCHEMBL30293291 | 0.73 | ALDH1A1 (0.33) | — | |
| SCHEMBL1030696 | 0.71 | CALM1 (0.35) | CALM1LOXL2 | |
| SCHEMBL11422173 | 0.70 | TDP1 (0.37) | — | |
| SCHEMBL1030650 | 0.70 | LTA4H (0.38) | — | |
| SCHEMBL2522629 | 0.70 | HDAC3 (0.39) | — | |
| SCHEMBL8037730 | 0.69 | MEN1 (0.35) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12077552-B2 | Synthesis of fluoroalkyl tin precursors | ENTEGRIS, INC. (US) | 2024-09-03 | — | — | US | disclosed |
| EP-4402147-A1 | SYNTHESIS OF FLUOROALKYL TIN PRECURSORS | Entegris, Inc. (US) | 2024-07-24 | — | — | EP | disclosed |
| CN-117957235-A | Synthesis of fluoroalkyl tin precursors | 恩特格里斯公司 | 2024-04-30 | — | — | CN | disclosed |
| US-20230098280-A1 | SYNTHESIS OF FLUOROALKYL TIN PRECURSORS | ENTEGRIS, INC. | 2023-03-30 | — | — | US | disclosed |
| WO-2023043682-A1 | SYNTHESIS OF FLUOROALKYL TIN PRECURSORS | ENTEGRIS, INC. (US) | 2023-03-23 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230098280-A1 | SYNTHESIS OF FLUOROALKYL TIN PRECURSORS | NISCH, NACA, PNN | CALM1 4458/4885LOXL2 2696/4885 |
| US-12077552-B2 | Synthesis of fluoroalkyl tin precursors | NISCH, NACA, PNN | CALM1 4458/4885LOXL2 2696/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.